LabCorp and Ciox Health Enter Collaboration to Create Comprehensive Patient Data Registry
Summary
BURLINGTON, N.C. & ALPHARETTA, Ga.--(BUSINESS WIRE)--LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, and Ciox Health, the leader in health information management for more than 30 years, today announced an agreement to collaborate on a comprehensive U.S.-based COVID-19 patient data registry. This patient data registry is expected to enable researchers to better understand and characterize COVID-19 diagnoses and treatments and generate insights that will aid ongoing and future pandemic preparedness and prevention efforts. “Healthcare practitioners and researchers need dynamic and real-time insights about COVID-19 to address this health care crisis and develop better treatment options for patients,” said Lance Berberian, chief information and technology officer, LabCorp. Once developed, there will be an opportunity to expand the capability to foster a data coalition that includes leading healthcare providers and other partners, such as state and federal public health organizations. “A comprehensive data set will yield valuable insights and we are ready to support researchers and public health organizations to advance our collective understanding of this pandemic.
Classifications
AskAI Classifications
LabelsLinked Companies
